This inventor holds 2 USPTO granted patents and 5 published patent applications, plus 2 CIPO patents and 2 EPO patents. Top assignees: University of Pennsylvania, Inovio Pharmaceuticals, Inc.. Active years: 2012-2015.
Company Filing History:
2 out of 2,651 
1 out of 93 
Years Active: 2012-2015
Title: The Innovations of Jean D Boyer
Introduction
Jean D Boyer is a notable inventor based in Haddonfield, NJ (US). He has made significant contributions to the field of molecular biology, particularly in the development of nucleic acid molecules and their applications in immunology. With a total of 2 patents, Boyer's work has implications for therapeutic strategies in immune modulation.
Latest Patents
Boyer's latest patents include groundbreaking innovations in nucleic acid molecules encoding RANTES. These patents disclose nucleic acid molecules comprising a nucleotide sequence encoding RANTES and its fragments and variants. The inventions also cover recombinant viral vectors and live attenuated pathogens that utilize these nucleotide sequences. Additionally, Boyer has developed methods for modulating immune responses and inducing immune responses against immunogens. His other patent focuses on fusion proteins and nucleic acid molecules encoding these proteins, which have applications in vaccine development and immunotherapy.
Career Highlights
Throughout his career, Jean D Boyer has worked with prestigious institutions such as the University of Pennsylvania and Inovio Pharmaceuticals, Inc. His research has contributed to advancements in immunology and therapeutic interventions, showcasing his expertise in the field.
Collaborations
Boyer has collaborated with notable colleagues, including David B Weiner and Michele Kutzler. These partnerships have further enhanced the impact of his research and innovations in the scientific community.
Conclusion
Jean D Boyer is a distinguished inventor whose work in nucleic acid molecules and immunology has paved the way for new therapeutic approaches. His contributions continue to influence the field and inspire future innovations.